Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Shapiro

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research StudyC H Miller, A S Rice, B Boylan, et al.
The Journal of Pediatrics|June 1, 1994
Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development StudyJ M Gertner, F R Kaufman, S M Donfield, et al.
Journal of Thrombosis and Haemostasis : JTH|February 28, 2009
Major differences in bleeding symptoms between factor VII deficiency and hemophilia BF Bernardi, A Dolce, M Pinotti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 11, 2012
Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centresM Escobar, J Maahs, E Hellman, et al.
Clinical Case Reports|January 7, 2026
Massive Intra-Abdominal Pseudotumor in a Patient With Hemophilia A Treated With Emicizumab: A Case ReportC J Kilach, C Njuguna, F Njuguna, et al.
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Clinical and laboratory phenotype variability in type 2M von Willebrand diseaseA L Doruelo, S L Haberichter, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia AA D Shapiro, J N Mahlangu, D Perry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methodsE Berntorp, J Astermark, S M Donfield, et al.
Seminars in Hematology|April 9, 2004
Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UKB M Ewenstein, P Collins, M D Tarantino, et al.
American Journal of Hematology|July 1, 1990
Excess of red cell membrane proteins in hereditary high-phosphatidylcholine hemolytic anemiaP A Lane, F A Kuypers, M R Clark, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|April 23, 2013
Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research StudyC H Miller, A S Rice, B Boylan, et al.
The Journal of Pediatrics|June 1, 1994
Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development StudyJ M Gertner, F R Kaufman, S M Donfield, et al.
Journal of Thrombosis and Haemostasis : JTH|February 28, 2009
Major differences in bleeding symptoms between factor VII deficiency and hemophilia BF Bernardi, A Dolce, M Pinotti, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 11, 2012
Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centresM Escobar, J Maahs, E Hellman, et al.
Clinical Case Reports|January 7, 2026
Massive Intra-Abdominal Pseudotumor in a Patient With Hemophilia A Treated With Emicizumab: A Case ReportC J Kilach, C Njuguna, F Njuguna, et al.
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Clinical and laboratory phenotype variability in type 2M von Willebrand diseaseA L Doruelo, S L Haberichter, P A Christopherson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2017
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia AA D Shapiro, J N Mahlangu, D Perry, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2005
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methodsE Berntorp, J Astermark, S M Donfield, et al.
Seminars in Hematology|April 9, 2004
Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UKB M Ewenstein, P Collins, M D Tarantino, et al.
American Journal of Hematology|July 1, 1990
Excess of red cell membrane proteins in hereditary high-phosphatidylcholine hemolytic anemiaP A Lane, F A Kuypers, M R Clark, et al.
Pageof 8